1. Home
  2. THAR vs MOVE Comparison

THAR vs MOVE Comparison

Compare THAR & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THAR
  • MOVE
  • Stock Information
  • Founded
  • THAR 2017
  • MOVE 2018
  • Country
  • THAR United States
  • MOVE United States
  • Employees
  • THAR N/A
  • MOVE N/A
  • Industry
  • THAR Biotechnology: Pharmaceutical Preparations
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • THAR Health Care
  • MOVE Health Care
  • Exchange
  • THAR Nasdaq
  • MOVE Nasdaq
  • Market Cap
  • THAR 5.5M
  • MOVE 4.5M
  • IPO Year
  • THAR 2022
  • MOVE 2021
  • Fundamental
  • Price
  • THAR $3.68
  • MOVE $1.08
  • Analyst Decision
  • THAR Strong Buy
  • MOVE
  • Analyst Count
  • THAR 1
  • MOVE 0
  • Target Price
  • THAR $17.00
  • MOVE N/A
  • AVG Volume (30 Days)
  • THAR 29.2M
  • MOVE 7.2M
  • Earning Date
  • THAR 11-06-2025
  • MOVE 09-19-2025
  • Dividend Yield
  • THAR N/A
  • MOVE N/A
  • EPS Growth
  • THAR N/A
  • MOVE N/A
  • EPS
  • THAR N/A
  • MOVE N/A
  • Revenue
  • THAR N/A
  • MOVE $1,013,000.00
  • Revenue This Year
  • THAR N/A
  • MOVE $1,460.71
  • Revenue Next Year
  • THAR N/A
  • MOVE $96.77
  • P/E Ratio
  • THAR N/A
  • MOVE N/A
  • Revenue Growth
  • THAR N/A
  • MOVE N/A
  • 52 Week Low
  • THAR $0.95
  • MOVE $0.51
  • 52 Week High
  • THAR $9.08
  • MOVE $6.97
  • Technical
  • Relative Strength Index (RSI)
  • THAR 50.85
  • MOVE 67.63
  • Support Level
  • THAR $4.94
  • MOVE $0.86
  • Resistance Level
  • THAR $7.25
  • MOVE $1.31
  • Average True Range (ATR)
  • THAR 1.50
  • MOVE 0.14
  • MACD
  • THAR -0.08
  • MOVE 0.05
  • Stochastic Oscillator
  • THAR 32.49
  • MOVE 68.88

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: